Accellix Expands its Leadership Team
Accellix, the Cell Therapy QC Company Raises $9.5 Million Series D Round
Accellix, Inc. Announces Their Next Generation Accellix Instrument and Consumable to Further Simplify and Automate the QC Workflow in Cell Therapy Manufacturing
Accellix, Inc. Announces the Appointment of Nir Nimrodi as Chairman and Chief Executive Officer. Nimrodi Will Lead the Company's Accelerated Growth as It Launches Custom and Standardized Panel Assays to Be Used by Its Expanding Installed Base.
Accellix, Inc. Announces the Appointment of Nir Nimrodi as Chairman and Chief Executive Officer. Nimrodi Will Lead the Company's Accelerated Growth as It Launches Custom and Standardized Panel Assays to Be Used by Its Expanding Installed Base.
Orgenesis Announces Co-Development Agreement with Accellix
Partners
Accellix, Inc Expands Leadership Team and Announces Name Change
Emosis and Accellix Announce Intent to Form a Joint Venture, EmoCellix
Partners
http://www.marketwired.com/press-release/leukodx-ge-healthcare-enter-agreement-explore-solutions-cell-characterization-cell-therapy-2106534.htm
LeukoDx Inc. Closes $7M Financing Round;Appoints Seymour Liebman & Mark Chess to BOD
Investment
LeukoDx Closes $1.6M Financing Tranche, Inks Agreements for up to $8M
InvestmentPartners
